HealthcareTherapeuticsArtificial IntelligenceGene TherapyGenetic Engineering https://finaldose.ai/ ↗
Company facts
Early-stage
- Founded
- 2026
- Employees
- 5
- Headquarters
- United Kingdom
About
FinalDose is building the first programmable drug - a single smart drug molecule that you can insert any diseased genetic code and it can search and destroy cells upon DNA recognition. Unlocking 80% of undruggable targets today. Starting with all cancers.